Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|July 9, 2014
Equipment and Processing Report
- Equipment and Processing Report-07-16-2014
- Volume 0
- Issue 0
Plastic Combination Conveyor Chain Increases Wear Life Without Lubrication
A hygiene-grade conveyor chain from FB Chain improves wear compared to stainless-steel chains.
A corrosion-resistant, plastic combination (PC) conveyor chain from FB Chain is designed for pharmaceutical manufacturing and meets EU hygiene standards. The chain is constructed from detection-grade engineering plastic inner links, supported by 304-grade stainless-steel bearing pins and outer link plates. The PC chain matches the strength of standard stainless-steel chain but has a much lower friction coefficient, eliminating the need for lubrication and increasing wear life. The PC chain is also quieter and lighter than stainless-steel chain. The bushed design of the plastic inner link eliminates the risk of residue becoming trapped between the chain components in wash-down applications. FB Chain’s PC chain is dimensionally interchangeable with stainless-steel chain; no adjustments to sprockets or other existing conveyor components are required to accommodate it.
Source:
Articles in this issue
about 12 years ago
Flexible Packaging Machines Maximize Efficiencyabout 12 years ago
Ensuring Ergonomic Design in Sterile Transfer Portsabout 12 years ago
Survey Shows Importance of Process Analytical Technologyover 12 years ago
Adapter Aids Positioning of Syringes in AutoinjectorsRelated to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
Complying with International Pharmacopoeias
4
Q&A: Patient-Centric Drug Development Should Start at Product Definition
5